- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Ind-Swift Laboratories' board has announced a board meeting outcome. The key takeaway: The Board has approved the financial results for the quarter ended June 30, 2025. This includes both the standalone and consolidated unaudited results, paving the way for their public disclosure. This move is crucial as it offers a glimpse into the company's recent performance. No dividends, fundraising plans, or major strategic developments were announced at this meeting, keeping the focus solely on the quarterly earnings.